Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Cas9 Technology Market

ID: MRFR/ICT/63088-HCR
200 Pages
Aarti Dhapte
Last Updated: February 06, 2026

India Cas9 Technology Market Size, Share and Trends Analysis Report By Application (Genome Engineering, Disease Models, In Vitro Genetic Depletion), By Product Type (Consumables, Vectors), By Delivery Method (Physical Delivery Methods, Viral Delivery Methods, Non-Viral Delivery Methods) and By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Information and Communications Technology, BY Product Type (USD Million)
      1. 4.1.1 Consumables
      2. 4.1.2 Vectors
    2. 4.2 Information and Communications Technology, BY Application (USD Million)
      1. 4.2.1 Genome Engineering
      2. 4.2.2 Disease Models
      3. 4.2.3 In Vitro Genetic Depletion
    3. 4.3 Information and Communications Technology, BY Delivery Method (USD Million)
      1. 4.3.1 Physical Delivery Methods
      2. 4.3.2 Viral Delivery Methods
      3. 4.3.3 Non-Viral Delivery Methods
    4. 4.4 Information and Communications Technology, BY End User (USD Million)
      1. 4.4.1 Biotechnology & Pharmaceutical Companies
      2. 4.4.2 Academic & Research Institutes
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Information and Communications Technology
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Information and Communications Technology
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Editas Medicine (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 CRISPR Therapeutics (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Intellia Therapeutics (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Caribou Biosciences (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Cellectis (FR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Regeneron Pharmaceuticals (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Beam Therapeutics (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Precision BioSciences (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 INDIA MARKET ANALYSIS BY APPLICATION
    4. 6.4 INDIA MARKET ANALYSIS BY DELIVERY METHOD
    5. 6.5 INDIA MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF INFORMATION AND COMMUNICATIONS TECHNOLOGY
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF INFORMATION AND COMMUNICATIONS TECHNOLOGY
    9. 6.9 DRIVERS IMPACT ANALYSIS: INFORMATION AND COMMUNICATIONS TECHNOLOGY
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: INFORMATION AND COMMUNICATIONS TECHNOLOGY
    11. 6.11 SUPPLY / VALUE CHAIN: INFORMATION AND COMMUNICATIONS TECHNOLOGY
    12. 6.12 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY PRODUCT TYPE, 2024 (% SHARE)
    13. 6.13 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY APPLICATION, 2024 (% SHARE)
    15. 6.15 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY APPLICATION, 2024 TO 2035 (USD Million)
    16. 6.16 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DELIVERY METHOD, 2024 (% SHARE)
    17. 6.17 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DELIVERY METHOD, 2024 TO 2035 (USD Million)
    18. 6.18 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY END USER, 2024 (% SHARE)
    19. 6.19 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY END USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
      3. 7.2.3 BY DELIVERY METHOD, 2025-2035 (USD Million)
      4. 7.2.4 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

India Information and Communications Technology Market Segmentation

Information and Communications Technology By Product Type (USD Million, 2025-2035)

  • Consumables
  • Vectors

Information and Communications Technology By Application (USD Million, 2025-2035)

  • Genome Engineering
  • Disease Models
  • In Vitro Genetic Depletion

Information and Communications Technology By Delivery Method (USD Million, 2025-2035)

  • Physical Delivery Methods
  • Viral Delivery Methods
  • Non-Viral Delivery Methods

Information and Communications Technology By End User (USD Million, 2025-2035)

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions